Published in BMJ Open on December 19, 2011
Global Prevalence of Chronic Kidney Disease - A Systematic Review and Meta-Analysis. PLoS One (2016) 1.17
Reducing the costs of chronic kidney disease while delivering quality health care: a call to action. Nat Rev Nephrol (2017) 0.92
Creatinine-or cystatin C-based equations to estimate glomerular filtration in the general population: impact on the epidemiology of chronic kidney disease. BMC Nephrol (2013) 0.92
Change in prevalence of chronic kidney disease in England over time: comparison of nationally representative cross-sectional surveys from 2003 to 2010. BMJ Open (2014) 0.89
Performance of Cockcroft-Gault, MDRD, and CKD-EPI in estimating prevalence of renal function and predicting survival in the oldest old. BMC Geriatr (2013) 0.85
The need for improved identification and accurate classification of stages 3-5 Chronic Kidney Disease in primary care: retrospective cohort study. PLoS One (2014) 0.83
Exploration of chronic kidney disease prevalence estimates using new measures of kidney function in the health survey for England. PLoS One (2015) 0.79
Chronic kidney disease: identification and management in primary care. Pragmat Obs Res (2016) 0.75
Impact on cardiovascular risk follow-up from a shift to the CKD-EPI formula for eGFR reporting: a cross-sectional population-based primary care study. BMJ Open (2013) 0.75
Trends in serum creatinine testing in Oxfordshire, UK, 1993-2013: a population-based cohort study. BMJ Open (2015) 0.75
What is the relationship between renal function and visit-to-visit blood pressure variability in primary care? Retrospective cohort study from routinely collected healthcare data. BMJ Open (2016) 0.75
Multicenter epidemiological study to assess the population of CKD patients in Greece: results from the PRESTAR study. PLoS One (2014) 0.75
The Oxford Renal (OxRen) cross-sectional study of chronic kidney disease in the UK. BMJ Open (2013) 0.75
Pitfalls in the Measurements and Assesment of Glomerular Filtration Rate and How to Escape them. EJIFCC (2012) 0.75
Requirement for cystatin C testing in chronic kidney disease: a retrospective population-based study. Br J Gen Pract (2017) 0.75
Cystatin C as a predictor of cardiovascular outcomes in a hypertensive population. J Hum Hypertens (2017) 0.75
K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis (2002) 81.62
A new equation to estimate glomerular filtration rate. Ann Intern Med (2009) 71.41
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med (2004) 49.19
Prevalence of chronic kidney disease in the United States. JAMA (2007) 38.98
Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med (2006) 32.81
Evaluation of the modification of diet in renal disease study equation in a large diverse population. J Am Soc Nephrol (2007) 6.00
Comparative performance of the CKD Epidemiology Collaboration (CKD-EPI) and the Modification of Diet in Renal Disease (MDRD) Study equations for estimating GFR levels above 60 mL/min/1.73 m2. Am J Kidney Dis (2010) 3.87
Chronic kidney disease is common: what do we do next? Nephrol Dial Transplant (2008) 3.41
Risk implications of the new CKD Epidemiology Collaboration (CKD-EPI) equation compared with the MDRD Study equation for estimated GFR: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Kidney Dis (2010) 3.37
Modification of the CKD epidemiology collaboration (CKD-EPI) equation for Japanese: accuracy and use for population estimates. Am J Kidney Dis (2010) 2.47
Comparison of the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) study equations: risk factors for and complications of CKD and mortality in the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis (2011) 1.88
Evaluation of the Chronic Kidney Disease Epidemiology Collaboration equation for estimating the glomerular filtration rate in multiple ethnicities. Kidney Int (2010) 1.81
A software upgrade: CKD testing in 2010. Am J Kidney Dis (2010) 1.15
MDRD or CKD-EPI study equations for estimating prevalence of stage 3 CKD in epidemiological studies: which difference? Is this difference relevant? BMC Nephrol (2010) 1.03
Chronic kidney disease prevalence and secular trends in a UK population: the impact of MDRD and CKD-EPI formulae. QJM (2011) 0.95
Sodium balance in renal failure. Curr Opin Nephrol Hypertens (1997) 0.94
Comparison of the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) study equations: prevalence of and risk factors for diabetes mellitus in CKD in the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis (2011) 0.88
Relationship between bacterial strain type, host biomarkers, and mortality in Clostridium difficile infection. Clin Infect Dis (2013) 3.15
Apolipoproteins in diabetes dyslipidaemia in South Asians with young adult-onset diabetes: distribution, associations and patterns. Ann Clin Biochem (2009) 1.43
The role of the physician in laboratory medicine: a European perspective. J Clin Pathol (2012) 1.39
The rise of cholesterol testing: how much is unnecessary. Br J Gen Pract (2011) 1.27
Population-based study of behavior immediately after transient ischemic attack and minor stroke in 1000 consecutive patients: lessons for public education. Stroke (2010) 1.14
Oncogenic hypophosphataemic osteomalacia: biomarker roles of fibroblast growth factor 23, 1,25-dihydroxyvitamin D3 and lymphatic vessel endothelial hyaluronan receptor 1. Eur J Endocrinol (2008) 1.05
Questionnaire study of the association between patient numbers and regular visiting by general practitioners in care homes. Age Ageing (2012) 0.96
Asymptomatic children with multiple endocrine neoplasia type 1 mutations may harbor nonfunctioning pancreatic neuroendocrine tumors. J Clin Endocrinol Metab (2009) 0.92
Transsternal thymectomy for myasthenia gravis: surgical outcome. Ann Thorac Surg (2006) 0.92
The PSA testing dilemma: GPs' reports of consultations with asymptomatic men: a qualitative study. BMC Fam Pract (2007) 0.89
Measurement of urinary metanephrines to screen for pheochromocytoma in an unselected hospital referral population. Clin Chem (2006) 0.88
The evidence underpinning sports performance products: a systematic assessment. BMJ Open (2012) 0.88
What influences men's decision to have a prostate-specific antigen test? A qualitative study. Fam Pract (2007) 0.87
GH replacement does not increase the risk of recurrence in patients with craniopharyngioma. Clin Endocrinol (Oxf) (2006) 0.86
Mutational analysis of the adaptor protein 2 sigma subunit (AP2S1) gene: search for autosomal dominant hypocalcemia type 3 (ADH3). J Clin Endocrinol Metab (2014) 0.81
Philosophy of science and the diagnostic process. Fam Pract (2013) 0.80
Confusing genes: a patient with MEN2A and Cushing's disease. Clin Endocrinol (Oxf) (2013) 0.80
Under-reporting of socioeconomic status of patients in stroke trials: adherence to CONSORT principles. Stroke (2013) 0.79
Diagnostic accuracy of urine dipstick testing in screening for microalbuminuria in type 2 diabetes: a cohort study in primary care. Fam Pract (2012) 0.78
Non-focal neurological symptoms associated with classical presentations of transient ischaemic attack: qualitative analysis of interviews with patients. PLoS One (2013) 0.78
Hyperglycemia and death in cystic fibrosis-related diabetes. Diabetes Care (2011) 0.78
Neonatal plasma TSH--estimated upper reference intervals for diagnosis and follow up of congenital hypothyroidism. Scand J Clin Lab Invest (2011) 0.78
Local suture annuloplasty for posterior mitral valve repair: 18-year experience. Asian Cardiovasc Thorac Ann (2011) 0.77
Impact on cardiovascular risk follow-up from a shift to the CKD-EPI formula for eGFR reporting: a cross-sectional population-based primary care study. BMJ Open (2013) 0.75
Determining the validity of hospital laboratory reference intervals for healthy young adults participating in early clinical trials of candidate vaccines. Hum Vaccin Immunother (2013) 0.75
Transient neurological symptoms in the older population: report of a prospective cohort study--the Medical Research Council Cognitive Function and Ageing Study (CFAS). BMJ Open (2013) 0.75
Renoprotective effects of renin-angiotensin-system inhibitors. Lancet (2006) 0.75
The Oxford Renal (OxRen) cross-sectional study of chronic kidney disease in the UK. BMJ Open (2013) 0.75
Gene targeting through o-methylated catecholamine metabolite patterns. Clin Chem (2011) 0.75
Age and hormone replacement therapy as factors influencing androgen levels in the postmenopausal female. Clin Chem Lab Med (2009) 0.75